GNBT - Goldman Small Cap Research Initiates Generex Coverage With $40 PPS Pre-Dividend
November 05 2018 - 10:36AM
InvestorsHub NewsWire
Goldman Small Cap Research - November 5, 2018
Every once in a while, we see an unusual situation and write
about it to alert you to it. Today is one of those days. Normally
idea would not be of a diversified health care stock that went from
$2 to $25 (before settling back) in about a month. But, in this
situation, there are interesting circumstances regarding a big
stock dividend and an aggressive M&A strategy to match its
R&D pipeline. News about an unusual dividend came out this
morning and prompted this email. Against this backdrop, we issued a
research report and an interview with the CEO this morning. Let me
introduce it to you…
FAST FACTS
-
Almost overnight, Generex Biotechnology (OTC –
GNBT) could go from also-ran to a firm generating revenue at an
annual run-rate of hundreds of millions annually. The Company just
closed on an acquisition that has generated $100M or more annually
in recent years and is primed to grow dramatically as it begins to
offer its services in 30 states, versus 3 this year.
-
There are more deals in the pipeline. Generex plans to become a
diversified health care firm that utilizes cash from its high
growth M&A targets to help fund its R&D in the areas where
an unmet need exists. These include diabetes, breast cancer,
prostate cancer and others.
-
Generex announced a 20:1 stock dividend with a record date of
Friday (which means investors must own the stock by Tuesday or
Wednesday to be eligible to receive it). While there is likely to
be a re-adjustment in share price as a result, the current market
capitalization, compared with its likely revenue next year (via
M&A) and underlying value of its portfolio, appears to be at a
major discount.
The recent Generex Biotechnology (OTC –
GNBT) Research Report is included below:
Goldman Small Cap Research has also recenlty initatied research on
Puration, Inc. (PURA),
Alternet Systems, Inc. (ALYI)
and Enviro-Serv (EVSV).
Source: http://www.goldmanresearch.com/201811051217/Opportunity-Research/new-interview-with-gnbt-ceo-and-a-new-research-report.html
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Apr 2023 to Apr 2024
Real-Time news about Puration Inc (CE) (OTCMarkets): 0 recent articles
More Puration Inc. (PC) News Articles